ריטלין LA ® 30 מ"ג כמוסות בשחרור מושהה ישראל - עברית - Ministry of Health

ריטלין la ® 30 מ"ג כמוסות בשחרור מושהה

novartis pharma services ag - methylphenidate hydrochloride 30 mg - capsules - methylphenidate - attention deficit hyperactivity disorder (adhd).

ריטלין LA ® 20 מ"ג כמוסות בשחרור מושהה ישראל - עברית - Ministry of Health

ריטלין la ® 20 מ"ג כמוסות בשחרור מושהה

novartis pharma services ag - methylphenidate hydrochloride 20 mg - capsules - methylphenidate - attention deficit hyperactivity disorder (adhd).

מדיקינט MR כמוסות בשחרור מושהה 20 מ"ג ישראל - עברית - Ministry of Health

מדיקינט mr כמוסות בשחרור מושהה 20 מ"ג

mediline ltd. - methylphenidate hydrochloride 20 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

מודיקיט MR כמוסות בשחרור מושהה 30 מ"ג ישראל - עברית - Ministry of Health

מודיקיט mr כמוסות בשחרור מושהה 30 מ"ג

mediline ltd. - methylphenidate hydrochloride 30 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient.treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

מדיקינט MR כמוסות בשחרור מושהה 40 מ"ג ישראל - עברית - Ministry of Health

מדיקינט mr כמוסות בשחרור מושהה 40 מ"ג

mediline ltd. - methylphenidate hydrochloride 40 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

ריוואסטיגמין אינובמד 1.5 מ"ג ישראל - עברית - Ministry of Health

ריוואסטיגמין אינובמד 1.5 מ"ג

inovamed ltd - rivastigmine as hydrogen tartrate 1.5 mg - capsules - rivastigmine - symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

מטופירון 250 ישראל - עברית - Ministry of Health

מטופירון 250

cts ltd - metyrapone 250 mg - capsules - metyrapone - diagnostic test of secondary adrenocortical insufficiency, treatment of resistant edema associated with increased aldosterone secretion.

לנסו 15 ישראל - עברית - Ministry of Health

לנסו 15

taro international ltd - lansoprazole 15 mg - capsules - proton pump inhibitors - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (gord) or duodenal ulcer. prevention of relapse in patients with gord or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome.treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.

לנסו 30 מ"ג ישראל - עברית - Ministry of Health

לנסו 30 מ"ג

taro international ltd - lansoprazole 30 mg - capsules - proton pump inhibitors - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (gord) or duodenal ulcer. prevention of relapse in patients with gord or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome. treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.

דיאסרין טבע ® ישראל - עברית - Ministry of Health

דיאסרין טבע ®

teva pharmaceutical indust.ltd - diacerein 50 mg - capsules - other antiinflammatory and antirheumatic agents, non steroids - symptomatic treatment of functional symptoms of osteoarthritis.